Amdocs (NASDAQ:DOX) Reaches New 52-Week Low – Here’s What Happened

Amdocs Limited (NASDAQ:DOXGet Free Report) hit a new 52-week low during trading on Wednesday . The stock traded as low as $69.47 and last traded at $69.69, with a volume of 357819 shares changing hands. The stock had previously closed at $73.13.

Analyst Ratings Changes

A number of analysts have issued reports on DOX shares. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday. Barclays cut their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Stifel Nicolaus decreased their price objective on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Finally, Bank of America reduced their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $92.33.

Check Out Our Latest Research Report on Amdocs

Amdocs Price Performance

The company has a quick ratio of 1.17, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. The business has a fifty day moving average of $80.07 and a 200 day moving average of $82.08. The firm has a market cap of $7.53 billion, a P/E ratio of 13.52, a PEG ratio of 1.30 and a beta of 0.40.

Amdocs (NASDAQ:DOXGet Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. The company had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business’s revenue was up 4.1% on a year-over-year basis. During the same period last year, the firm posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, sell-side analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a dividend yield of 3.3%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s payout ratio is presently 43.91%.

Hedge Funds Weigh In On Amdocs

Several institutional investors and hedge funds have recently made changes to their positions in DOX. William Blair Investment Management LLC grew its holdings in Amdocs by 2.4% in the 2nd quarter. William Blair Investment Management LLC now owns 5,650 shares of the technology company’s stock valued at $516,000 after buying an additional 133 shares in the last quarter. Mutual Advisors LLC boosted its position in shares of Amdocs by 3.2% in the second quarter. Mutual Advisors LLC now owns 4,516 shares of the technology company’s stock valued at $397,000 after acquiring an additional 138 shares during the period. MGO One Seven LLC grew its stake in shares of Amdocs by 5.1% in the second quarter. MGO One Seven LLC now owns 2,899 shares of the technology company’s stock valued at $264,000 after acquiring an additional 140 shares in the last quarter. Scotia Capital Inc. increased its position in Amdocs by 3.5% during the third quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after acquiring an additional 145 shares during the period. Finally, Huntington National Bank raised its stake in Amdocs by 5.0% in the 2nd quarter. Huntington National Bank now owns 3,273 shares of the technology company’s stock worth $299,000 after purchasing an additional 155 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Company Profile

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Featured Articles

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.